Qi Song

1.9k total citations
50 papers, 1.0k citations indexed

About

Qi Song is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Qi Song has authored 50 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 19 papers in Oncology and 14 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Qi Song's work include Cancer-related molecular mechanisms research (8 papers), Lung Cancer Treatments and Mutations (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Qi Song is often cited by papers focused on Cancer-related molecular mechanisms research (8 papers), Lung Cancer Treatments and Mutations (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Qi Song collaborates with scholars based in China, United States and Philippines. Qi Song's co-authors include Shunchang Jiao, Yi Hu, Guoqiang Wang, Ye Li, Jinliang Wang, Zhibo Zhang, Quanbo Ji, Xiang Yan, Yameng Xu and Min Peng and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Qi Song

48 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Qi Song China 19 523 377 321 209 101 50 1.0k
Xuequan Yao China 20 494 0.9× 305 0.8× 313 1.0× 172 0.8× 149 1.5× 37 921
Liang Shang China 17 685 1.3× 425 1.1× 212 0.7× 227 1.1× 137 1.4× 64 1.1k
Chao Ma China 21 620 1.2× 473 1.3× 234 0.7× 269 1.3× 93 0.9× 91 1.2k
Haohai Zhang China 17 372 0.7× 291 0.8× 201 0.6× 130 0.6× 71 0.7× 27 784
Liqiao Fan China 20 585 1.1× 423 1.1× 170 0.5× 205 1.0× 129 1.3× 71 965
Jiliang Shen China 13 644 1.2× 353 0.9× 259 0.8× 201 1.0× 120 1.2× 29 1.1k
Min Kang China 17 549 1.0× 432 1.1× 159 0.5× 213 1.0× 92 0.9× 66 964
Masayuki Nagahashi Japan 14 503 1.0× 287 0.8× 394 1.2× 178 0.9× 134 1.3× 27 1.0k
Zhijun Min China 16 453 0.9× 291 0.8× 197 0.6× 195 0.9× 116 1.1× 25 865

Countries citing papers authored by Qi Song

Since Specialization
Citations

This map shows the geographic impact of Qi Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qi Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qi Song more than expected).

Fields of papers citing papers by Qi Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qi Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qi Song. The network helps show where Qi Song may publish in the future.

Co-authorship network of co-authors of Qi Song

This figure shows the co-authorship network connecting the top 25 collaborators of Qi Song. A scholar is included among the top collaborators of Qi Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Qi Song. Qi Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Song, Qi, Zhiliang Jin, Han Zhang, et al.. (2025). Fusobacterium nucleatum-derived 3-indolepropionic acid promotes colorectal cancer progression via aryl hydrocarbon receptor activation in macrophages. Chemico-Biological Interactions. 414. 111495–111495. 3 indexed citations
3.
Sun, Zhuo, Xiao Chen, J. S. Yu, et al.. (2025). Impact of different front-of-package labeling models on food choices among residents in Shanghai, China: a randomized controlled trial. Frontiers in Nutrition. 12. 1594807–1594807. 1 indexed citations
4.
Song, Qi, Jie Bai, Jiayu Li, et al.. (2024). Phosvitin-based hydrogels prepared in AmimCl under magnetic field treatment: Structural characteristics, biological functions, and application in skin wound healing. International Journal of Biological Macromolecules. 259(Pt 2). 129224–129224. 2 indexed citations
5.
Song, Qi, et al.. (2024). A study on the efficacy and Safety Evaluation of a novel PD-1/CTLA-4 bispecific antibody. Immunobiology. 229(6). 152844–152844.
6.
Wang, Biao, et al.. (2024). FOXA1/UBE2T Inhibits CD8+T Cell Activity by Inducing Mediates Glycolysis in Lung Adenocarcinoma. Frontiers in Bioscience-Landmark. 29(4). 134–134. 9 indexed citations
7.
Xie, Peiyi, Bo Zhang, Qi Song, et al.. (2022). Case report: immunotherapy successfully treated brain metastasis in intrahepatic cholangiocarcinoma and literature review. Frontiers in Oncology. 12. 911202–911202. 5 indexed citations
8.
Jiang, Dongxian, Qi Song, Yufeng Liu, et al.. (2022). PMS2 Expression With Combination of PD-L1 and TILs for Predicting Survival of Esophageal Squamous Cell Carcinoma. Frontiers in Oncology. 12. 897527–897527. 1 indexed citations
9.
Xu, Tao, et al.. (2021). Identification of RHEX as a novel biomarker related to progression and immunity of non-small cell lung carcinoma. Translational Cancer Research. 10(8). 3811–3828. 2 indexed citations
11.
Song, Qi, Jianguo Zhao, Jian Ruan, et al.. (2020). Identification of plasma hsa_circ_0008673 expression as a potential biomarker and tumor regulator of breast cancer. Journal of Clinical Laboratory Analysis. 34(9). e23393–e23393. 35 indexed citations
12.
Wu, Pengbo, Tian Tian, Jinbo Zhao, et al.. (2020). IRE1α-JNK pathway-mediated autophagy promotes cell survival in response to endoplasmic reticulum stress during the initial phase of hepatic steatosis. Life Sciences. 264. 118668–118668. 14 indexed citations
13.
Yao, Yan, Tingting Zhang, Lingyu Qi, et al.. (2020). Comprehensive analysis of prognostic biomarkers in lung adenocarcinoma based on aberrant lncRNA–miRNA–mRNA networks and Cox regression models. Bioscience Reports. 40(1). 17 indexed citations
14.
16.
Han, Lu, et al.. (2018). MicroRNA-128 contributes to the progression of gastric carcinoma through GAREM-mediated MAPK signaling activation. Biochemical and Biophysical Research Communications. 504(1). 295–301. 19 indexed citations
17.
Ji, Quanbo, Xiaojie Xu, Yameng Xu, et al.. (2018). Cryptotanshinone Protects Cartilage against Developing Osteoarthritis through the miR-106a-5p/GLIS3 Axis. Molecular Therapy — Nucleic Acids. 11. 170–179. 26 indexed citations
18.
Li, An, Dandan Li, Qiao Zhang, et al.. (2017). Terfenadine combined with epirubicin impedes the chemo-resistant human non-small cell lung cancer both in vitro and in vivo through EMT and Notch reversal. Pharmacological Research. 124. 105–115. 63 indexed citations
19.
Dai, Guo, Di Zheng, Qianliang Wang, et al.. (2017). Baicalein inhibits progression of osteosarcoma cells through inactivation of the Wnt/β-catenin signaling pathway. Oncotarget. 8(49). 86098–86116. 31 indexed citations
20.
Pan, Zhiqiang, et al.. (2016). Genetic polymorphisms and haplotype of hormone-related genes are associated with the risk of breast cancer in Chinese women. Genetics and Molecular Research. 15(2). 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026